Evidence map›Paper›PMID 36965506›Full record

ArticleJournal of the American Medical Directors Association2023

Resident Factors Associated With Breakthrough SARS-CoV-2 Infections.

Ana Montoya, Katherine Wen, Jasmine L Travers, Maricruz Rivera-Hernandez, Elizabeth White, Vincent Mor, Sarah D Berry

Abstract read
In one paragraph

Article in Journal of the American Medical Directors Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Incidence of Long COVID Diagnoses in 3.6 Million U.S. Medicare Beneficiaries With COVID-19.The journals of gerontology. Series A, Biological sciences and medical sciences · 2025
    Article
  4. Review
  5. Observational
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ana MontoyaDivision of Geriatric and Palliative Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI, USA. Electronic address: amontoya@med.umich.edu.
Katherine WenDepartment of Medicine, Health, and Society, Vanderbilt University, Nashville, TN, USA.
Jasmine L TraversRory Meyers College of Nursing, New York University, New York, NY, USA.
Maricruz Rivera-HernandezDepartment of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, RI, USA.
Elizabeth WhiteDepartment of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, RI, USA.
Vincent MorDepartment of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, RI, USA.
Sarah D BerryHinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, MA, USA; Department of Medicine & Harvard Medical Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Funding

Training Core (I)U54AG063546 · NIA · BROWN UNIVERSITY · PI Vincent Mor · 2019 to 2026
$125.9M
NIA NIH HHS U54 AG063546
6 · The paper itself

Abstract

objectiveTo examine incidence of and resident characteristics associated with breakthrough infections (BTIs) and severe illness among residents with 2 messenger RNA (mRNA) vaccinations.

designRetrospective cohort study. SETTING AND

participantsNursing home (NH) residents who completed their primary series of mRNA COVID-19 vaccination by March 31, 2021.

methodsElectronic health records and Minimum Data Set assessments from a multistate NH data consortium were used to identify BTI and severe illness (a composite measure of hospitalization and/or death within 30 days of BTI) occurring prior to November 24, 2021. A t test for differences in means was used to compare covariates for residents with and without BTI. Finally, we estimated incidence rate ratios (IRRs) for BTI with 95% CIs using a modified Poisson regression approach, comparing residents with BTI vs residents without. We adjusted for facility fixed effects in our model.

resultsOur sample included 23,172 residents from 984 NHs who were at least 14 days past their second mRNA vaccine dose. Of those, 1173 (5%) developed an incident COVID-19 BTI (mean follow-up time: 250 days). Among residents with BTI, 8.6% were hospitalized or died within 30 days of BTI diagnosis. Factors associated with severe illness included age ≥85 years (IRR 2.08, 95% CI 1.08-4.02, reference age <65 years), bowel incontinence (IRR 1.73, 95% CI 1.01-2.99), coronary artery disease (IRR 1.96, 95% CI 1.31-2.94), chronic kidney disease (IRR 1.65, 95% CI 1.07-2.54), and schizophrenia (IRR 2.38, 95% CI 1.19-4.75). CONCLUSIONS AND IMPLICATIONS: Among vaccinated NH residents, BTIs and associated severe illness are rare. Residents aged ≥85 years and with certain comorbidities appear to be the most vulnerable. Given that the pandemic continues and testing policies have relaxed, these data provide prognostic information for NH facilities faced with continued outbreaks.

Indexed as

COVID-19COVID-19 VaccinesHumansNursing HomesRetrospective StudiesSARS-CoV-2COVID-19 Vaccinesbreakthrough infectionsCOVID-19nursing homes

Identifiers

PMID36965506
PMCPMC9977610

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.